Chondrocyte and mesenchymal stem cell derived engineered cartilage exhibits differential sensitivity to pro‐inflammatory cytokines

Abstract

Tissue engineering is a promising approach for the repair of articular cartilage defects, with engineered constructs emerging that match native tissue properties. However, the inflammatory environment of the damaged joint might compromise outcomes, and this may be impacted by the choice of cell source in terms of their ability to operate anabolically in an inflamed environment. Here, we compared the response of engineered cartilage derived from native chondrocytes and mesenchymal stem cells (MSCs) to challenge by TNFα and IL-1β in order to determine if either cell type possessed an inherent advantage. Compositional (extracellular matrix) and functional (mechanical) characteristics, as well as the release of catabolic mediators (matrix metalloproteinases [MMPs], nitric oxide [NO]) were assessed to determine cell- and tissue-level changes following exposure to IL-1β or TNF-α. Results demonstrated that MSC-derived constructs were more sensitive to inflammatory mediators than chondrocyte-derived constructs, exhibiting a greater loss of proteoglycans and functional properties at lower cytokine concentrations. While MSCs and chondrocytes both have the capacity to form functional engineered cartilage in vitro, this study suggests that the presence of an inflammatory environment is more likely to impair the in vivo success of MSC-derived cartilage repair. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: Recommendations of the ORS spine section

“…As discs degenerate, even in the early stages, this biochemical environment is further characterized by increasing local catabolic cytokine expression and acidity . Therapeutic cell types such as MSCs are more sensitive to microenvironmental stressors such as oxygen, nutrient deprivation and inflammatory stimuli compared to endogenous cells …”

“…113 Therapeutic cell types such as MSCs are more sensitive to microenvironmental stressors such as oxygen, nutrient deprivation and inflammatory stimuli compared to endogenous cells. [114][115][116] For in vitro cell culture models, mimicking this in vivo disc microenvironment can be accomplished by culturing cells in low oxygen, and reduced glucose and serum, to simulate nutrient deprivation. [115][116][117] The degenerate environment can be further simulated by including catabolic mediators such as inflammatory cytokines and by increasing acidity.…”

LncRNA NKILA integrates RXFP1/AKT and NF‐κB signalling to regulate osteogenesis of mesenchymal stem cells

“…Mesenchymal stem cells (MSCs), a type of pluripotent stem cells with potential ability to differentiate into multilineage cells such as osteocytes, adipocytes and chondrocyte when exposed to in vitro specific induction, can be isolated from multiple tissues. Due to its multipotency, MSCs‐based therapy is widely accepted as a promising candidate for clinical treatment in the area of regenerative medicine, especially bone tissue repair and regeneration.…”

MicroRNA‐29b regulates hypertrophy of murine mesenchymal stem cells induced toward chondrogenesis

“…Mesenchymal stem cells (MSCs) possess certain advantages, including pluripotent differentiation, immunomodulatory properties, paracrine, and self‐renewal . MSCs have been paid close attention to as a cellular therapy for cartilage repair and osteoarthritis (OA) .…”